Navigation Links
Poor Sense of Smell May Be Early Sign of Parkinson's
Date:3/29/2008

Those with lowest odor identification scores had 5 times greater risk, study finds

FRIDAY, March 28 (HealthDay News) -- An impaired sense of smell could be an early indicator of Parkinson's disease, occurring up to four years before motor skill problems appear, recent research shows.

The study, published in the February issue of the Annals of Neurology, followed 2,267 men who received olfactory testing at the Kuakini Medical Center in Honolulu at least once during two periods in the 1990s. They were followed for up to eight years and, during that time, 35 of the men developed the disease.

An odor identification problem preceded the development of Parkinson's by at least four years in these men. Decreased odor identification was associated with older age, smoking, more coffee consumption, less frequent bowel movements, lower cognitive function and excessive daytime sleepiness, but even after adjusting for these factors, those with the lowest odor identification scores had a five times greater risk of developing Parkinson's than those with the highest scores.

The results strengthen findings from earlier studies that suggest olfactory impairment begins between two and seven years before diagnosis.

Why problems with smelling accompany Parkinson's is not completely understood; however, nerve loss and the formation of Lewy bodies -- abnormal clumps of proteins inside nerve cells that are thought to be a marker of the disease -- are known to take place in the olfactory structures of patients with the disease.

The study authors noted that one previous study involving brain dissection of deceased patients with neurological disease found that olfactory structures are the earliest brain regions affected by Lewy degeneration, which supports the idea that an impaired sense of smell could be one of the earliest signs of Parkinson's disease.

An impaired sense of smell could also be caused by impaired sniffing, which may be another motor symptom of Parkinson's.

Olfactory testing, along with screening for other potential early indicators of Parkinson's disease such as constipation or sleep disturbances, could provide a simple and relatively economic means of identifying individuals at high risk who could participate in trials of medications designed to prevent or slow disease progression, the authors concluded in a prepared statement.

More information

The National Institute of Neurological Disorders and Stroke has more about Parkinson's disease.



-- Kevin McKeever



SOURCE: American Neurological Association, news release, March 20, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Antisense therapeutics scientist out to pull more big deals
2. Impaired sense of smell may be early indicator of Parkinsons disease
3. New Scenic Relaxation Videos Help Reduce Stress, Promote Sense of Calm and Tranquility
4. Sense of personal control influences Latinas decisions about sexual debut
5. URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards
6. Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
7. How do we make sense of what we see?
8. Bayer Awards Making Science Make Sense Grant to Girl Scouts
9. Redsense Medical Receives FDA Approval for Blood Loss Detection Device
10. Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
11. Majority of House of Representatives Support Common-Sense Fix to Medicare Part D Prescription Drug Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: